Global /Sweden /Healthcare /Medical Devices /BACTI-B
chevron_leftBack
Bactiguard Holding AB (publ) logo

Bactiguard Holding AB (publ)

BACTI-B
STO: BACTI-B Delayed
18.00SEK -2.7%
1.92 USD
As of 5 June 2026, Bactiguard Holding AB (publ) has a market cap of $67.06M USD, ranking #28415 globally and #375 in Sweden. It ranks #2576 in the Healthcare sector, and #526 in the Medical Devices industry.
Global Rank
28415
Country Rank
375
Sector Rank
2576
Industry Rank
526
Key Stats
Market Cap
$67.06MUSD
630.79M SEK
Enterprise Value
$80.74MUSD
756.75M SEK
Revenue (TTM)
$21.39MUSD
201.18M SEK
EBITDA (TTM)
$3.33MUSD
31.22M SEK
Net Income (TTM)
-$922.54KUSD
-8.68M SEK
EBITDA Margin
16%
Profit Margin
-4.3%
Forward PE
266.7
PS Ratio
3.1
PB Ratio
2.0
EV/EBITDA
17.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Christine Lind open_in_new
Employees
157
Founded
2005
Website
bactiguard.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-2.7% 3.1% 12% 6.4% 12% -44%

News

Loading...

Markets

Exchange Ticker Price
Nasdaq Stockholm
MIC: XSTO
PRIMARY
BACTI-B
Bactiguard Holding AB
ISIN: SE0005878741
Shares Out.:
31.044M1 Shares Float: 13.438M2
TV:
SA:
YF:
GF:
BA:
MS:
18.00 SEK
London Stock Exchange
MIC: XLON
0QV2
ISIN: SE0005878741
TV:
SA:
YF:
GF:
BA:
MS:
16.20 SEK
Frankfurt Stock Exchange
MIC: XFRA
5JE
Bactiguard Holding AB
ISIN: SE0005878741
TV:
SA:
YF:
GF:
BA:
5JE
MS:
1.55 EUR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Bactiguard Holding AB (publ)

Bactiguard Holding AB (publ), a medTech company, provides infection prevention technology and solutions in orthopedics, cardiology, neurology, urology, and vascular access areas. It also operates through license partnerships with global MedTech companies that apply the technology to medical devices and sell them under own brand and co-branded. The company also has a portfolio of wound management products, such as Hydrocyn Aqua, an antimicrobial solution and gel for improved wound healing; and surgical sutures comprising non-absorbable, natural absorbable, synthetic absorable, and specialty sutures. It operates in the United States, Sweden, Malaysia, India, Bangladesh, Indonesia, the Kingdom of Saudi Arabia, and internationally. The company has licensed partnership with Becton, Dickinson & Company for urinary catheter bardex IC and lubrisil IC; Well Lead Medical for catheters and tubes; and Zimmer Biomet for orthopedic trauma implants. The company was founded in 2005 and is headquartered in Stockholm, Sweden.

Similar Companies

Industry: Medical Devices (Sweden)
Name
Market Cap diff.
PE
GETI-B
$5.57B
52.4B SEK
8K%
22.2
SCIB
$4.84B
45.5B SEK
7K%
-
EKTA-B
$2.22B
20.86B SEK
3K%
-
$1.58B
14.87B SEK
2K%
-
$1.52B
14.32B SEK
2K%
78.5
$904.13M
8.5B SEK
1K%
115.1
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
$173.27B
258K%
25.8
$160.73B
240K%
56.7
$159.07B
237K%
25.6
DHR
$126.55B
189K%
34.7
SYK
$120.69B
180K%
38.3
MDT
$101.9B
152K%
22.2
chevron_leftBack